Search

Your search keyword '"Forconi, Francesco"' showing total 186 results

Search Constraints

Start Over You searched for: Author "Forconi, Francesco" Remove constraint Author: "Forconi, Francesco" Search Limiters Academic (Peer-Reviewed) Journals Remove constraint Search Limiters: Academic (Peer-Reviewed) Journals
186 results on '"Forconi, Francesco"'

Search Results

3. Activity of venetoclax in patients with relapsed or refractory chronic lymphocytic leukaemia: analysis of the VENICE-1 multicentre, open-label, single-arm, phase 3b trial

5. BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib

6. Ibrutinib and rituximab versus fludarabine, cyclophosphamide, and rituximab for patients with previously untreated chronic lymphocytic leukaemia (FLAIR): interim analysis of a multicentre, open-label, randomised, phase 3 trial

7. High surface IgM levels associate with shorter response to ibrutinib and BTK bypass in patients with CLL

11. Acalabrutinib monotherapy in patients with Waldenström macroglobulinemia: a single-arm, multicentre, phase 2 study

13. Genome-wide association study identifies risk loci for progressive chronic lymphocytic leukemia

15. Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia

17. IL-4 enhances expression and function of surface IgM in CLL cells

20. The PI3K/mTOR inhibitor PF-04691502 induces apoptosis and inhibits microenvironmental signaling in CLL and the Eµ-TCL1 mouse model

21. DNA methylation profiling identifies two splenic marginal zone lymphoma subgroups with different clinical and genetic features

23. Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome

26. Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia

27. Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia

28. The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation

29. The host genetic background of DNA repair mechanisms is an independent predictor of survival in diffuse large B-cell lymphoma

30. Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome

32. Development of a distributed international patient data registry for hairy cell leukemia.

33. Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia.

34. Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia

37. Hairy cell leukemias with unmutated IGHV genes define the minor subset refractory to single-agent cladribine and with more aggressive behavior

38. BCL2 Inhibition in Refractory Hairy-Cell Leukemia.

39. TP53 Mutations Identified Using NGS Comprise the Overwhelming Majority of TP53 Disruptions in CLL: Results From a Multicentre Study.

46. The coexistence of chronic lymphocytic leukemia and myeloproliperative neoplasms: A retrospective multicentric GIMEMA experience

49. BRAF Mutations in Hairy-Cell Leukemia

Catalog

Books, media, physical & digital resources